JNJ-41443532
JNJ-41443532 (CCR2 antagonist 5) is a selective, orally active hCCR2 inhibitor with good binding affinity (IC50=37 nM) and potent functional antagonism (chemotaxis IC50=30 nM) . JNJ-41443532 displays a Ki of 9.6 μM for mCCR2 binding. JNJ-41443532 can be used in the research of inflammatory disease[1].
Product Specifications
CAS Number
[1228650-83-6]
Product Name Alternative
CCR2 antagonist 5
UNSPSC
12352005
Target
CCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jnj-41443532.html
Purity
99.65
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(CNC(C1=CC(C(F)(F)F)=CC=C1)=O)NC2CN(C2)[C@](CC3)([H])CC[C@@]3(C4=CN=CS4)O
Molecular Formula
C22H25F3N4O3S
Molecular Weight
482.52
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CCR2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LRRK1 (Leucine-rich Repeat Kinase 1, Leucine-rich Repeat Serine/threonine-protein Kinase 1, FLJ23119, FLJ27465, KIAA1790, RIPK6, Roco1) (MaxLight 750)
LRRK1 (Leucine-rich Repeat Kinase 1, Leucine-rich Repeat Serine/threonine-protein Kinase 1, FLJ23119, FLJ27465, KIAA1790, RIPK6, Roco1) (MaxLight 750)
